Likewise, coagulation factor V (F5) was significantly increased in COVID‐19 patients, whereas modulators of coagulation such as the beta‐2‐glycoprotein 1 (APOH), histidine‐rich glycoprotein (HRG), and fibronectin (FN1) were decreased. Here, F5 is linked to COVID-19.